Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Chiho Yabuta"'
Autor:
Thomas R. Shearer, Chiho Yabuta, Seiko Kozai, Mitsuyoshi Azuma, Yayoi Kishimoto, Ayumi Mori, Akira Ohtori
Publikováno v:
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics. 33(7)
To establish the in silico ocular pharmacokinetic modeling for eye drops, and to simulate the dose regimen for FK962 in human choroid/retinal diseases.Pharmacokinetics for FK962 in vivo was performed by a single instillation of drops containing 0.1%T
Publikováno v:
Ophthalmic Research. 51:96-103
Background/Aims: To investigate if galectin-3: (1) enhances adhesion of rat corneal epithelial cells onto a collagen IV substrate and (2) promotes wound healing in rat corneal explants. Methods: Primary cultures of rat corneal epithelial cells were f
Autor:
Mitsuyoshi Azuma1,2 (AUTHOR), Chiho Yabuta1 (AUTHOR), Frederick W. Fraunfelder3 (AUTHOR), Thomas R. Shearer2 (AUTHOR) shearert@ohsu.edu
Publikováno v:
BMC Research Notes. 2014, Vol. 7 Issue 1, p1-3. 3p. 1 Chart, 1 Graph.
Publikováno v:
Investigative Opthalmology & Visual Science. 53:5312
Purpose Amputation of the trigeminal nerve leads to decreased corneal sensitivity and dry eye. Our previous study showed that the drug FK962 (N-[1-acetylpiperidin-4-yl]-4-fluorobenzamide) induced neurite elongation from trigeminal ganglion (TG) cells
Autor:
Akira Ohtori, Mitsuyoshi Azuma, Takayuki Oka, Chiho Yabuta, Ayumi Yoshimatsu, Yayoi Kishimoto
Publikováno v:
American Journal of Ophthalmology. 153:651-660.e1
Purpose To test if the drug FK962 (N-(1-acetylpiperidin-4-yl)-4-fluorobenzamide) facilitates axonal elongation and recovery of corneal sensitivity after creation of a corneal flap in rabbits. Design Animal study. Methods Primary cultures of rabbit tr
Publikováno v:
BMC Research Notes
Background Increasing age is a known risk factor for developing dry eye. The specific aims of the present study were to determine the prevalence of dry eye syndrome (DES) and use of post-operative dry eye medications in a relatively young population